Fidelity Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $430M | Buy |
2,275,762
+1,474,837
| +184% | +$258M | 0.02% | 568 |
|
|
2025
Q4 | $136M | Buy |
800,925
+118,789
| +17% | +$18.2M | 0.01% | 1038 |
|
|
2025
Q3 | $89.9M | Buy |
682,136
+134,609
| +25% | +$16.1M | ﹤0.01% | 1232 |
|
|
2025
Q2 | $58.1M | Sell |
547,527
-213,975
| -28% | -$23.2M | ﹤0.01% | 1338 |
|
|
2025
Q1 | $94.5M | Buy |
761,502
+19,197
| +3% | +$2.5M | 0.01% | 1117 |
|
|
2024
Q4 | $91.4M | Sell |
742,305
-93,576
| -11% | -$11M | 0.01% | 1154 |
|
|
2024
Q3 | $93.1M | Sell |
835,881
-87,943
| -10% | -$9.64M | 0.01% | 1131 |
|
|
2024
Q2 | $98.6M | Sell |
923,824
-36,555
| -4% | -$4.02M | 0.01% | 1044 |
|
|
2024
Q1 | $116M | Sell |
960,379
-268,612
| -22% | -$32.9M | 0.01% | 997 |
|
|
2023
Q4 | $151M | Sell |
1,228,991
-104,138
| -8% | -$13M | 0.01% | 859 |
|
|
2023
Q3 | $173M | Buy |
1,333,129
+100,349
| +8% | +$13.4M | 0.01% | 760 |
|
|
2023
Q2 | $153M | Buy |
1,232,780
+126,616
| +11% | +$17M | 0.01% | 829 |
|
|
2023
Q1 | $162M | Sell |
1,106,164
-199,482
| -15% | -$29.5M | 0.01% | 795 |
|
|
2022
Q4 | $208M | Buy |
1,305,646
+99,953
| +8% | +$14.6M | 0.02% | 663 |
|
|
2022
Q3 | $161M | Sell |
1,205,693
-394,811
| -25% | -$60M | 0.02% | 758 |
|
|
2022
Q2 | $250M | Sell |
1,600,504
-153,373
| -9% | -$23.6M | 0.02% | 620 |
|
|
2022
Q1 | $273M | Buy |
1,753,877
+110,633
| +7% | +$16.1M | 0.02% | 663 |
|
|
2021
Q4 | $209M | Sell |
1,643,244
-1,473,348
| -47% | -$194M | 0.02% | 789 |
|
|
2021
Q3 | $406M | Sell |
3,116,592
-328,811
| -10% | -$49.7M | 0.03% | 506 |
|
|
2021
Q2 | $612M | Sell |
3,445,403
-89,654
| -3% | -$15.5M | 0.05% | 371 |
|
|
2021
Q1 | $581M | Buy |
3,535,057
+666,338
| +23% | +$110M | 0.05% | 379 |
|
|
2020
Q4 | $473M | Buy |
2,868,719
+87,803
| +3% | +$13.1M | 0.04% | 424 |
|
|
2020
Q3 | $397M | Buy |
2,780,916
+1,185,464
| +74% | +$147M | 0.04% | 390 |
|
|
2020
Q2 | $176M | Buy |
1,595,452
+94,313
| +6% | +$10.4M | 0.02% | 657 |
|
|
2020
Q1 | $150M | Buy |
1,501,139
+112,997
| +8% | +$14.6M | 0.02% | 610 |
|
|
2019
Q4 | $207M | Sell |
1,388,142
-437,858
| -24% | -$59.6M | 0.02% | 636 |
|
|
2019
Q3 | $234M | Sell |
1,826,000
-1,033,344
| -36% | -$139M | 0.03% | 578 |
|
|
2019
Q2 | $408M | Sell |
2,859,344
-554,315
| -16% | -$74.5M | 0.05% | 381 |
|
|
2019
Q1 | $488M | Sell |
3,413,659
-1,177,608
| -26% | -$154M | 0.06% | 315 |
|
|
2018
Q4 | $569M | Sell |
4,591,267
-1,157,476
| -20% | -$172M | 0.08% | 247 |
|
|
2018
Q3 | $967M | Sell |
5,748,743
-886,215
| -13% | -$152M | 0.11% | 172 |
|
|
2018
Q2 | $1.14B | Buy |
6,634,958
+715,595
| +12% | +$117M | 0.13% | 150 |
|
|
2018
Q1 | $894M | Sell |
5,919,363
-966,529
| -14% | -$142M | 0.11% | 191 |
|
|
2017
Q4 | $927M | Sell |
6,885,892
-1,156,692
| -14% | -$160M | 0.11% | 196 |
|
|
2017
Q3 | $1.18B | Sell |
8,042,584
-247,826
| -3% | -$37.5M | 0.14% | 142 |
|
|
2017
Q2 | $1.29B | Buy |
8,290,410
+849,348
| +11% | +$130M | 0.16% | 125 |
|
|
2017
Q1 | $1.08B | Sell |
7,441,062
-24,553
| -0.3% | -$3.2M | 0.14% | 153 |
|
|
2016
Q4 | $814M | Sell |
7,465,615
-1,293,068
| -15% | -$144M | 0.11% | 197 |
|
|
2016
Q3 | $1.06B | Sell |
8,758,683
-45,794
| -0.5% | -$6.17M | 0.14% | 152 |
|
|
2016
Q2 | $1.24B | Sell |
8,804,477
-113,017
| -1% | -$16.7M | 0.17% | 126 |
|
|
2016
Q1 | $1.16B | Sell |
8,917,494
-158,066
| -2% | -$19.7M | 0.16% | 128 |
|
|
2015
Q4 | $1.28B | Sell |
9,075,560
-50,649
| -0.6% | -$7.02M | 0.17% | 120 |
|
|
2015
Q3 | $1.21B | Buy |
9,126,209
+159,098
| +2% | +$27.4M | 0.17% | 122 |
|
|
2015
Q2 | $1.58B | Buy |
8,967,111
+30,862
| +0.3% | +$5.54M | 0.2% | 99 |
|
|
2015
Q1 | $1.54B | Buy |
8,936,249
+24,899
| +0.3% | +$4.27M | 0.2% | 110 |
|
|
2014
Q4 | $1.46B | Buy |
8,911,350
+260,983
| +3% | +$43.3M | 0.19% | 113 |
|
|
2014
Q3 | $1.39B | Buy |
8,650,367
+2,710,013
| +46% | +$417M | 0.19% | 113 |
|
|
2014
Q2 | $873M | Buy |
5,940,354
+367,562
| +7% | +$51M | 0.12% | 184 |
|
|
2014
Q1 | $773M | Buy |
5,572,792
+654,085
| +13% | +$98.5M | 0.11% | 198 |
|
|
2013
Q4 | $623M | Buy |
4,918,707
+466,009
| +10% | +$48.2M | 0.09% | 254 |
|
|
2013
Q3 | $410M | Buy |
4,452,698
+642,501
| +17% | +$51.8M | 0.06% | 354 |
|
|
2013
Q2 | $262M | Buy |
+3,810,197
| New | +$233M | 0.04% | 477 |
|
Other funds holding JAZZ
VPM
VCM
EC
Fidelity Investments's JAZZ Position: Q1 2026 in Review
Fidelity Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 184% in Q1 2026, buying an estimated $258M and bringing the position to 2,275,762 shares worth $430M. The position accounts for 0.02% of the portfolio, ranked #568.
Fidelity Investments first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.58B in Q2 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Fidelity Investments held 2,275,762 shares of Jazz Pharmaceuticals worth $430M as of Q1 2026.
- Fidelity Investments bought 1,474,837 Jazz Pharmaceuticals shares in Q1 2026, an estimated $258M.
- Jazz Pharmaceuticals made up 0.02% of Fidelity Investments's portfolio in Q1 2026, its #568 holding.
- Fidelity Investments first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Jazz Pharmaceuticals position peaked at $1.58B in Q2 2015.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.